Clarity Pharmaceuticals (ASX:CU6) Signs Copper-64 Supply Agreement with Nusano
Clarity Pharmaceuticals (ASX:CU6) secures a copper-64 supply agreement with Nusano to support clinical trials and commercialization.
Clarity Pharmaceuticals (ASX:CU6) secures a copper-64 supply agreement with Nusano to support clinical trials and commercialization.
Anatara Lifesciences (ASX:ANR) reports Phase II GaRP-IBS trial results, highlighting safety and significant improvements in anxiety scores.
Podium Minerals (ASX:POD) completes the EV Nickel acquisition and becomes the first Australian PGM developer to join the World Platinum Investment Council.
Streamplay Studio (ASX:SP8) launches Sacre Bleu globally on Nintendo Switch and Steam, marking its first title on these platforms.
Black Cat Syndicate Limited (ASX:BC8) pours first gold at Lakewood, marking a significant milestone in its Kal East gold production plan.
Ampol Limited (ASX:ALD) reports mid-single digit EBIT growth in Convenience Retail and New Zealand segments for 1Q 2025, while refiner margins decline 49%.
The Calmer Co International (ASX:CCO) announces nationwide distribution of Fiji Kava in Woolworths, strengthening its market presence.
Heartland Group (ASX:HGH) reports a strong Q3 with significant receivables growth and improved asset quality.
Rumble Resources (ASX:RTR) reports progress on Western Queen Mine development and high-grade exploration, with first ore mining expected by year-end.
Rimfire Pacific Mining (ASX:RIM) reports on its ongoing scandium drilling at Currajong, with assay results expected in late April.